Abstract Model-informed precision dosing (MIPD) stands as a significant development in
personalized medicine to tailor drug dosing to individual patient characteristics. MIPD moves …

Introduction Although there are well-defined guidelines for the management of mild-to-
moderate ulcerative colitis (UC), there are still unmet needs. For this reason, we conducted …

Background & Aims Pouchitis is the most common complication after restorative
proctocolectomy with ileal pouch–anal anastomosis for ulcerative colitis. This American …

Background & Aims Biomarkers are used frequently for evaluation and monitoring of
patients with Crohn's disease (CD). This American Gastroenterological Association (AGA) …

Intestinal dysfunction is becoming increasingly associated with neurological and endocrine
issues, raising concerns about its impact on world health. With the introduction of several …

Ulcerative colitis (UC) is a complex, refractory inflammatory bowel disease characterized
impared intestinal mucosal barrier and imbalanced M1/M2 macrophage polarization …

Managing inflammatory bowel disease (IBD) is becoming increasingly complex and
personalized, considering the advent of new advanced therapies with distinct mechanisms …

Background: Patients with inflammatory bowel diseases (IBD) require proactive monitoring
both during the active phase to evaluate therapeutic response and during the remission …

In this review, we have summarized the existing knowledge of ulcerative colitis (UC) markers
based on current literature, specifically, the roles of potential new biomarkers, such as …

Introduction The STRIDE consensus intends to complement the clinical endpoint with an
endoscopic endpoint of mucosal healing and others as treatment targets in ulcerative colitis …